"Centre hospitalier universitaire (CHU) de Besançon. Etablissement public de santé, qui assure une triple mission : soins, enseignement et recherche."

During the past decade, CHU de Besancon Hopital Jean Minjoz; Service de Neurologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHU de Besancon Hopital Jean Minjoz; Service de Neurologie" are "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Stroke" (1 trials). Many other conditions were trialed in "CHU de Besancon Hopital Jean Minjoz; Service de Neurologie" in a lesser frequency.

Most popular intervention types in "CHU de Besancon Hopital Jean Minjoz; Service de Neurologie" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Antihistamine" (1 trials), "Basmisanil" (1 trials), "Methylprednisolone" (1 trials) and "Ocrelizumab 300 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Besancon Hopital Jean Minjoz; Service de Neurologie" are 6 trials for "All" genders.

Currently, there are NaN active trials in "CHU de Besancon Hopital Jean Minjoz; Service de Neurologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU de Besancon Hopital Jean Minjoz; Service de Neurologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Besancon Hopital Jean Minjoz; Service de Neurologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".